Showing 3421-3430 of 7016 results for "".
Lowering Lipids Through Therapeutic Lifestyle Change
https://reachmd.com/programs/lipid-luminations/lowering-lipids-through-therapeutic-lifestyle-change/3943/Cindy Conroy, a registered dietitian at the Iowa Heart Center Lipid Clinic, discusses with host Dr. Larry Kaskel practical approaches to helping patients implement a successful lifestyle change program. Ms. Conroy emphasizes the importance of educating patients about the relationship between sugar iExploring New Developments in the Treatment of Recurrent C. Difficile
https://reachmd.com/programs/gi-insights/exploring-new-developments-in-the-treatment-of-recurrent-c-difficile/15948/What have been the new therapeutic developments for patients with recurrent C. difficile? Tune in.Genetic Testing to Improve Risk Assessment and Guide Therapies in Patients Facing Heart Disease
https://reachmd.com/programs/lipid-luminations/genetic-testing-to-improve-risk-assessment-and-guide-therapies-in-patients-facing-heart-disease/6481/Dr. Christie Ballantyne discusses with host Dr. Alan Brown the use of genetic testing in various phases of disease onset in patients facing heart disease. They talk about how clinicians can utilize the current technologies, what the costs are and the benefits. How does learning more about the genetiUnderstanding the Growing Burden of Early-Onset CRC
https://reachmd.com/programs/on-the-frontlines-of-colorectal-cancer/growing-burden-early-onset-crc/49178/Colorectal cancer is rising rapidly among adults under 50, often presenting at more advanced stages. Dr. Christopher Cann joins host Ryan Quigley to review key considerations for this population, including key diagnostic and therapeutic strategies, survivorship concerns, and multidisciplinary caIron Deposition and Cognitive Fatigue in Multiple Sclerosis
https://reachmd.com/programs/neurofrontiers/iron-deposition-and-cognitive-fatigue-in-ms/54234/Rising Popularity of MedSpas Brings Increased Scrutiny Nationwide
https://reachmd.com/topics/practice-development/rising-popularity-of-medspas-brings-increased-scrutiny-nationwide/54392/Legal, ownership, and scope-of-practice risks take center stage as the aesthetic market expandExploring T-DXd in HER2-Positive Breast Cancer Treatment
https://reachmd.com/programs/frontlines-metastatic-breast-cancer/tdxd-her2-positive-breast-cancer-treatment/39720/Trastuzumab deruxtecan (T-DXd) is reshaping treatment strategies for patients with HER2-positive breast cancer across both early and metastatic stages. With recent data from the DESTINY-Breast05 and DESTINY-Breast09 trials, the therapeutic potential of T-DXd continues to expand, offering improved ouChallenges and Opportunities in Migraine Management
https://reachmd.com/programs/frontlines-migraine/challenges-opportunities-migraine-management/48939/Migraine is a widespread and heterogeneous condition that presents unique challenges in diagnosis and treatment, with variability in patient response and limited access to therapies further complicating care. Joining Dr. Charles Turck to explore the evolving migraine landscape and strategies for oveFuture Directions in Managing Hyperkalemia in CKD and HF
https://reachmd.com/programs/cme/tbd/37676/Learn from a multidisciplinary faculty panel how to Improve outcomes for patients with CKD and HFrEF using optimal RAASi and MRAs while managing hyperkalemia with potassium binders.Case-Based Application: Optimizing RAASi/MRA Therapy with Potassium Binders
https://reachmd.com/programs/cme/tbd/37675/Learn from a multidisciplinary faculty panel how to Improve outcomes for patients with CKD and HFrEF using optimal RAASi and MRAs while managing hyperkalemia with potassium binders.